Sirona Biochem Corp. is a Canada-based, development-stage company. The Company is engaged in the discovery and development of drug compounds with a focus on treatments for Type II Diabetes and Obesity. It is specializes in the development of carbohydrate-based molecules. It is also focused on advancing three programs: therapeutics, cosmetic agents and biological ingredients. The Company�s wholly owned subsidiary, TFCHEM S.A.R.L (TFC), has developed a platform technology based upon fluorinated sugar mimics for the treatment of diabetes and obesity. TFC focuses on carrying out a two year research program to develop a chemical process to achieve the synthesis of a new class of Sodium Glucose Co-transporter Inhibitors for the treatment of Type II Diabetes and Obesity. On March 31, 2011, the Company completed the acquisition of TFCHEM S.A.R.L (TFC).